iCardio.ai, a Los Angeles-based company specializing in machine learning and deep learning algorithms for ultrasound analysis, is partnering with Abbott.

The collaboration aims to advance artificial intelligence within Abbott’s electrophysiology imaging products, essential for managing cardiac arrhythmias like atrial fibrillation.

Utilizing a database of over 200 million images, iCardio.ai will focus on automating model creation for Abbott’s EnSite X cardiac mapping system.

This will involve analyzing 2D intracardiac echo (ICE) images captured by Abbott’s ICE catheters.

The partnership aligns with iCardio.ai's mission to integrate AI into ultrasound technology and highlights its ongoing progress and innovation in the field.





Source: icardio.ai

Report Abuse